A B.C. doctor who helped discover an enzyme and develop a drug to stop the spread of SARS more than 20 years ago is using that knowledge to fight COVID-19.

Dr. Josef Penninger, a UBC life sciences institute director, co-discovered an enzyme called ACE2 while working as a researcher in Toronto in the late ’90s.

A few years later, during the SARS epidemic, Penninger discovered that ACE2 was the virus’ gateway into healthy cells, where they both replicated and destroyed tissue. In the case of SARS, it was lung tissue in particular.

He then developed a drug that blocked the enzyme and stopped the virus from entering healthy tissue.

Soon after, the number of SARS cases began to drop around the world — along with funding for clinical trials.

Story continues below advertisement

5:00
Trudeau warns of a second COVID wave in a special televised address

Trudeau warns of a second COVID wave in a special televised address

Read more:
B.C. teacher wasn’t told of COVID-19 case in cohort, later tests positive

When COVID-19, which is also a coronavirus like SARS, began to spread, Penninger resurrected his research.

Trending Stories



Trump signs executive order on health care; attracts criticism from Democrats



B.C. reports 148 new cases of COVID-19 and two new deaths, 30 school exposures

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

Due to his previous work during the SARS outbreak, he was able to begin clinical trials well before other researchers.

On Thursday, the promising findings of the first clinical trial of his new treatment were released in the Lancet Medical Journal.

The patient, a 45-year-old woman in Vienna who was on a ventilator due to severe COVID-19 symptoms, showed improvement shortly after receiving the drug known as APN01.

“In one or two days, the virus disappeared in her blood system and also in her lungs,” Penninger told Global News. “Secondly, the cytokine storm went down within two to three days. She developed perfect immunity from the virus.”

Story continues below advertisement

“She is now back home and healthy.”

A cytokine storm is an overreaction of the body’s immune system, which can be fatal if someone has COVID-19.

Study recruitment is still underway around the world, with the hope that the results from 200 other severe cases of COVID-19 patients will be published by November.

If all goes well, Penninger said there could be a drug ready for market by early next year.

View link »




© 2020 Global News, a division of Corus Entertainment Inc.



Source link